Loading organizations...
§ Private Profile · San Diego, CA, USA
Develops small molecule therapeutics for hematologic disorders.
HemaQuest Pharmaceuticals has raised $29.0M across 3 funding rounds.
HemaQuest Pharmaceuticals has raised $29.0M in total across 3 funding rounds.
HemaQuest Pharmaceuticals has raised $29.0M in total across 3 funding rounds.
HemaQuest Pharmaceuticals's investors include James Woody, Aberdare Ventures, De Novo Ventures, Forward Ventures, Lilly Ventures, Naheed Ismaili Misfeldt.
HemaQuest Pharmaceuticals has raised $29.0M across 3 funding rounds. Most recently, it raised $13.0M Series B Extension in March 2012.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 12, 2012 | $13M Series B Plus | — | — | Announced |
| Jul 28, 2010 | $4M Series B Plus | James Woody | Aberdare Ventures, DE Novo Ventures, Forward Ventures, Lilly Ventures | Announced |
| Apr 21, 2010 | $12M Series B | Naheed Ismaili Misfeldt | DE Novo Ventures, Forward Ventures, Lilly Ventures | Announced |